Of interest, sustained inhibition of PI3K-Akt signaling leads to a resurgence of Akt activity, indicated by increased phosphorylation of Akt at serine 473 and at threonine 308 residues in a breast cancer cell line (47). This evidence concerns the gene AKT1 and breast carcinoma.